The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Pilot study to evaluate the effect of erlotinib (E) administered before surgery in operable patients with squamous cell carcinoma of the head and neck (SCCHN).
M. Porosnicu
No relevant relationships to disclose
J. D. Waltonen
No relevant relationships to disclose
C. Sullivan
No relevant relationships to disclose
L. McWilliams
No relevant relationships to disclose
G. L. Kucera
No relevant relationships to disclose
A. Thomas
No relevant relationships to disclose
R. Plasser
No relevant relationships to disclose
J. D. Browne
No relevant relationships to disclose